Literature DB >> 18038271

Cardioprotection of neonatal heart using normothermic hyperkalaemia: the importance of delivery and terminal cardioplegia.

Hajime Imura1, M-Saadeh Suleiman.   

Abstract

Cardioprotection of immature hearts remains controversial and largely based on the use of hypothermic cardioplegia. Recent clinical trials in pediatric open-heart surgery suggest that normothermic cardioplegic arrest is also cardioprotective. However, the advantages of using normothermic cardioplegia delivered as single- or multi-dose with or without terminal cardioplegia are unknown. This work investigates the efficacy of these techniques and the mechanism(s) underlying their protective effect. Neonatal (7-10 days) rabbit hearts in a working mode were exposed to normothermic global ischemia (60 or 90 min) protected with one of the following cardioplegic (hyperkalaemic buffer) protocols: single-dose, multi-dose infused every 30 min, single-dose or multi-dose with terminal cardioplegia. The extent of functional recovery (e.g., aortic and coronary flow), ischemic stress (e.g., myocardial ATP, lactate) and reperfusion injury (lactate dehydrogenase (LDH) release) were assessed. Recovery following 60 min global ischemia was improved (p < 0.05) by single-dose and multi-dose cardioplegic delivery (from 5% to 60% and 80%, respectively). Improved recovery was augmented by 2 min terminal cardioplegia (to 90% and 97% for single-dose and multi-dose, respectively). Extending ischemia to 90 min with single-dose resulted in 0% recovery that was not improved by 2 min terminal cardioplegia. However, 5 min (not 10 min) terminal cardioplegia significantly improved recovery (32%). Multi-dose followed by 5 min terminal cardioplegia resulted in full recovery. Cardioprotective interventions were associated with a reduction in LDH release and attenuated changes in myocardial metabolites. During normothermic cardioplegic arrest of neonatal heart: (i) multi-dose is superior to single-dose; (ii) terminal cardioplegia confers additional protection to single-dose and multi-dose; and (iii) protection is likely to be due to metabolic preservation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18038271     DOI: 10.1007/s11010-007-9660-x

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  34 in total

Review 1.  Mitochondria: a target for myocardial protection.

Authors:  M S Suleiman; A P Halestrap; E J Griffiths
Journal:  Pharmacol Ther       Date:  2001-01       Impact factor: 12.310

2.  Warm surgery: our experience.

Authors:  Vincenzo Cassano; Leonardo Milella
Journal:  Eur J Cardiothorac Surg       Date:  2007-02-08       Impact factor: 4.191

Review 3.  Development of cardiac sensitivity to oxygen deficiency: comparative and ontogenetic aspects.

Authors:  B Ostadal; I Ostadalova; N S Dhalla
Journal:  Physiol Rev       Date:  1999-07       Impact factor: 37.312

4.  Reduction of postischemic myocardial damage by maintaining arrest during initial reperfusion.

Authors:  D M Follette; D L Steed; R P Foglia; K H Fey; G D Buckberg
Journal:  Surg Forum       Date:  1977

5.  Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery.

Authors:  H Imura; M Caputo; A Parry; A Pawade; G D Angelini; M S Suleiman
Journal:  Circulation       Date:  2001-03-20       Impact factor: 29.690

6.  Reducing postischemic reperfusion damage in neonates using a terminal warm substrate-enriched blood cardioplegic reperfusate.

Authors:  M T Kronon; B S Allen; S Rahman; T Wang; N A Tayyab; K S Bolling; M N Ilbawi
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

7.  Purine metabolism and release during cardioprotection with hyperkalemia and hypothermia.

Authors:  Hajime Imura; Ben E Ayres; M Saadeh Suleiman
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

8.  Comparison of single- and multi-dose crystalloid cardioplegia to protect the immature myocardium.

Authors:  H Kato; M Galiñanes; M J Elliott; M R de Leval; D J Hearse
Journal:  Eur J Cardiothorac Surg       Date:  1994       Impact factor: 4.191

9.  Single-dose versus multi-dose cardioplegia in the immature rat heart: studies with normothermic and hypothermic ischemia.

Authors:  E Riva; D J Hearse
Journal:  J Cardiovasc Surg (Torino)       Date:  1993-10       Impact factor: 1.888

10.  [Discontinuous warm cardioplegia in pediatric cardiac surgery: preliminary results].

Authors:  Y Durandy; S Hulin
Journal:  Arch Mal Coeur Vaiss       Date:  2006-02
View more
  1 in total

1.  Propofol protects the immature rabbit heart against ischemia and reperfusion injury: impact on functional recovery and histopathological changes.

Authors:  Makoto Shirakawa; Hajime Imura; Takashi Nitta
Journal:  Biomed Res Int       Date:  2014-08-27       Impact factor: 3.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.